Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Qbasis bucks the downward trend in managed futures with positive July performance

Thursday, August 21, 2014

Bailey McCann, Opalesque New York:

Austria-based Qbasis Invest, a managed futures fund focused on trend following and an intraday strategy posted another month of positive returns despite a down month for managed futures funds as a group. The iTrend flagship program was up +8.41% in July, following June's positive performance of +1.63%, according to performance documents obtained by Opalesque.

The iTrend index product which follows the broad strategy of the iTrend Fund was also up (gross): +23.76%.

The firm also manages an equity long/short strategy which posted gains of +3.77%. The product was launched late last year.

Qbasis said in a first half update that the firm's performance was supported by implementing strategy enhancements last year including "V-protection and Vol-protection models" that mitigate against V-shaped reversals and periods of declining volatility respectively.

"We've seen this time and time again this year where we've protected capital on days where even the very conservative industry benchmark has fallen more than our NAV," Qbasis CEO Philipp Pölzl wrote in a performance note at the time.

Managed futures funds as a cohort have faced difficulties in the recent market environment. Asset flows to the cohort have been negative for several months, alongside tepid performance. Managed futures funds saw outflows of $11.5 billion as of July, according to data from Eurkeahedge. All managed futures indices calculated by Ne......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its